MRI in rheumatoid arthritis and at-risk populations: the importance of context - Authors' reply [0.03%]
风湿性关节炎和高危人群的磁共振成像：背景的重要性——作者回复
Dennis A Ton,Nikolet K den Hollander,Hanna W van Steenbergen et al.
Dennis A Ton et al.
The Lancet Rheumatology
The Lancet Rheumatology
Sebastian Klapa,Peter Lamprecht
Sebastian Klapa
Pregnancy outcomes in patients with systemic vasculitis in the USA from 2007 to 2022: an administrative claims-based study [0.03%]
美国2007年至2022年系统性血管炎患者的妊娠结局：基于行政索赔的研究
Audra Horomanski,Amadeia Rector,Gary M Shaw et al.
Audra Horomanski et al.
Background: Systemic vasculitides are rare, heterogeneous, inflammatory disorders associated with high morbidity and mortality. Recent therapeutic advancements have improved life expectancy and reproductive opportunities ...
Revisiting safety and refining benefit of rituximab-belimumab combination for refractory SLE [0.03%]
利妥昔单抗联合贝利木单抗治疗难治性SLE的安全性再评估及疗效优化
Michael R Ehrenstein,Muhammad Shipa,Kashfia Chowdhury et al.
Michael R Ehrenstein et al.
Anti-BCMA CAR-T for the treatment of IgG4-related disease: clinical assessment and single-cell transcriptomic analysis [0.03%]
抗BCMA的CAR-T治疗IgG4相关性疾病：临床评估和单细胞转录组分析
Shaozhe Cai,Yu Chen,Cong Ye et al.
Shaozhe Cai et al.
Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study [0.03%]
Janus激酶抑制对类风湿关节炎患者骨骼肌影响的单臂研究（RAMUS研究）
Joshua L Bennett,Kieren G Hollingsworth,Arthur G Pratt et al.
Joshua L Bennett et al.
Background: Rheumatoid arthritis increases the risk of generalised muscle wasting, with chronic inflammation contributing to the loss of muscle mass and strength. Tofacitinib, a Janus kinase (JAK) inhibitor used to treat ...
Jin Kyun Park,Eun Bong Lee
Jin Kyun Park
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritis [0.03%]
类风湿关节炎临床疾病活动度、滑膜炎症特征与治疗反应的关系
Clément Triaille,Patrick Durez,Francesco Natalucci et al.
Clément Triaille et al.
Synovial tissue is widely considered to be a strong candidate for contributing to the development of individualised therapeutic strategies for the treatment and management of rheumatoid arthritis. Recently, several factors have enabled majo...